Yoshihiro Kawaokais a virologist specializing in the study of the influenza and Ebola viruses. He holds a professorship in virology at the University of Wisconsin-Madison, USA, and at the University of Tokyo, Japan... (wikipedia)
only one case, and whether that condition was something unique we don't know.
I don't think we need to panic based on this finding.
It is a mixture. Within the mixture we found virus that is highly, highly resistant. When you look at the virus as a whole, it is partially resistant.
Our findings provide a rational explanation for why H 5 N 1 viruses rarely infect and spread from human to human, although they can replicate efficiently in the lungs.
Patient 1 had not had any known direct contact with poultry, but had cared for her 21-year-old brother (patient 2) while he had a documented H5N1 virus infection,
We don't know how many more mutations are required. But at this point, we still have some time.
We don't know how frequently this kind of mutation can appear,
Application of the new system may be especially advantageous in situations of outbreaks of highly pathogenic avian influenza viruses.
This is the first line of defense. It is the drug many countries are stockpiling, and the plan is to rely heavily on it.
In that context, this is an important drug.
By reducing the number of plasmids, we increase the efficiency of virus production,